GANX Competitors & Alternatives
Compare Gain Therapeutics Inc with similar stocks in the same industry
Biotechnology
GANX
Main Stock$1.26
Tradestie Score
59
Market Cap
$65.43M
Revenue Growth
-1.0%
Analyst Upside
+471.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 48 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 49 | Compare |
|
COYA
Coya Therapeutics, Inc. Common Stock
|
$3.94
|
$97.84M | - | 46 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.98
|
$89.17M | - | 46 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 43 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$0.77
|
$83.60M | - | 34 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 58 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.05
|
$10.26M | - | 51 | Compare |
More GANX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry